Mycenax Biotech Inc. (TPEX:4726)
Taiwan
· Delayed Price · Currency is TWD 32.40
-0.30 (-0.92%)
At close: Dec 5, 2025
Mycenax Biotech Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 217.79 | 269.57 | 519.27 | 1,323 | 286.93 | 291.14 | Upgrade
|
| Short-Term Investments | - | 7.3 | 148.42 | 16.12 | - | - | Upgrade
|
| Cash & Short-Term Investments | 217.79 | 276.87 | 667.69 | 1,339 | 286.93 | 291.14 | Upgrade
|
| Cash Growth | -46.04% | -58.53% | -50.15% | 366.84% | -1.45% | 5.02% | Upgrade
|
| Accounts Receivable | 189.89 | 140.74 | 58.53 | 81.32 | 320.84 | 169.03 | Upgrade
|
| Other Receivables | 5.04 | 7.73 | 4.69 | 3.09 | 11.33 | 5.51 | Upgrade
|
| Receivables | 194.92 | 148.47 | 63.22 | 84.41 | 332.17 | 174.54 | Upgrade
|
| Inventory | 101.38 | 64.94 | 112.33 | 246.72 | 173.3 | 84.85 | Upgrade
|
| Prepaid Expenses | 73.37 | 71.45 | 83.25 | 103.22 | 89.28 | 23.82 | Upgrade
|
| Other Current Assets | 217.28 | 174.66 | 171.53 | 149.95 | 15.73 | 2.16 | Upgrade
|
| Total Current Assets | 804.75 | 736.38 | 1,098 | 1,924 | 897.41 | 576.51 | Upgrade
|
| Property, Plant & Equipment | 1,619 | 1,705 | 1,847 | 1,978 | 1,351 | 786.73 | Upgrade
|
| Long-Term Investments | 157.45 | 177.87 | 190.81 | 199.51 | 109.59 | 191.81 | Upgrade
|
| Goodwill | 23.92 | 23.92 | 23.92 | 23.92 | 23.92 | 23.92 | Upgrade
|
| Other Intangible Assets | 9.28 | 12.34 | 18.98 | 25.93 | 33.71 | 36.72 | Upgrade
|
| Long-Term Deferred Tax Assets | 100.86 | 98.6 | 95.49 | 89.72 | 81.11 | 83.45 | Upgrade
|
| Other Long-Term Assets | 613.57 | 614.67 | 495.85 | 211.93 | 642.46 | 53.41 | Upgrade
|
| Total Assets | 3,329 | 3,368 | 3,770 | 4,453 | 3,139 | 1,753 | Upgrade
|
| Accounts Payable | 39.4 | 34.63 | 44.05 | 52.52 | 54.68 | 40.31 | Upgrade
|
| Accrued Expenses | 90.25 | 98.05 | 112.32 | 104.21 | 96.4 | 66.6 | Upgrade
|
| Short-Term Debt | 280 | - | - | 100 | 50 | 100 | Upgrade
|
| Current Portion of Long-Term Debt | 196.55 | 168.08 | 125.92 | 105.88 | 15.6 | - | Upgrade
|
| Current Portion of Leases | 37.59 | 31.92 | 30.57 | 37.28 | 28.59 | 24.33 | Upgrade
|
| Current Income Taxes Payable | 0.01 | - | - | - | - | 0.65 | Upgrade
|
| Current Unearned Revenue | 384.98 | 230.85 | 187.28 | 142.28 | 152.12 | 125.9 | Upgrade
|
| Other Current Liabilities | 51.12 | 97.97 | 253.28 | 92.57 | 142.69 | 66.99 | Upgrade
|
| Total Current Liabilities | 1,080 | 661.5 | 753.42 | 634.73 | 540.07 | 424.78 | Upgrade
|
| Long-Term Debt | 482.81 | 611.37 | 530.4 | 656.32 | 474.4 | - | Upgrade
|
| Long-Term Leases | 123.75 | 72.04 | 39.39 | 56.37 | 176.06 | 72.28 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | - | 3.75 | 6.68 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 38.07 | 37.14 | Upgrade
|
| Total Liabilities | 1,686 | 1,345 | 1,323 | 1,347 | 1,232 | 540.89 | Upgrade
|
| Common Stock | 2,072 | 2,070 | 2,059 | 2,053 | 1,533 | 1,282 | Upgrade
|
| Additional Paid-In Capital | 62.66 | 421.11 | 1,074 | 1,468 | 576.95 | 53.11 | Upgrade
|
| Retained Earnings | -491.98 | -466.91 | -682.64 | -406.83 | -254.34 | -207.23 | Upgrade
|
| Comprehensive Income & Other | -0.1 | -0.79 | -3.32 | -8.8 | 50.72 | 83.41 | Upgrade
|
| Shareholders' Equity | 1,643 | 2,023 | 2,447 | 3,106 | 1,907 | 1,212 | Upgrade
|
| Total Liabilities & Equity | 3,329 | 3,368 | 3,770 | 4,453 | 3,139 | 1,753 | Upgrade
|
| Total Debt | 1,121 | 883.39 | 726.28 | 955.85 | 744.64 | 196.61 | Upgrade
|
| Net Cash (Debt) | -902.91 | -606.53 | -58.59 | 383.63 | -457.72 | 94.53 | Upgrade
|
| Net Cash Growth | - | - | - | - | - | -58.98% | Upgrade
|
| Net Cash Per Share | -4.36 | -2.94 | -0.29 | 2.32 | -3.08 | 0.73 | Upgrade
|
| Filing Date Shares Outstanding | 207.2 | 207.01 | 205.89 | 205.31 | 153.33 | 128.24 | Upgrade
|
| Total Common Shares Outstanding | 207.2 | 207.01 | 205.89 | 205.31 | 153.33 | 128.24 | Upgrade
|
| Working Capital | -275.15 | 74.89 | 344.59 | 1,289 | 357.34 | 151.73 | Upgrade
|
| Book Value Per Share | 7.93 | 9.77 | 11.89 | 15.13 | 12.43 | 9.45 | Upgrade
|
| Tangible Book Value | 1,609 | 1,987 | 2,404 | 3,056 | 1,849 | 1,151 | Upgrade
|
| Tangible Book Value Per Share | 7.77 | 9.60 | 11.68 | 14.88 | 12.06 | 8.98 | Upgrade
|
| Buildings | 792.86 | 792.86 | 792.86 | 791.68 | - | - | Upgrade
|
| Machinery | 1,595 | 1,594 | 1,603 | 1,575 | 837.57 | 688.02 | Upgrade
|
| Construction In Progress | 186.13 | 158.09 | 106.85 | 3.35 | 624.35 | 260.37 | Upgrade
|
| Leasehold Improvements | 325.48 | 325.53 | 317.34 | 307.77 | 276.23 | 246.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.